The global paracetamol market presented a varied pricing landscape in Q2 2025, shaped by raw material cost shifts, regulatory delays, and trade dependencies across major formulation hubs. According to IMARC Group’s latest publication, Paracetamol Price Trend, Index and Forecast Data Report 2025 Edition, which provides updated insights for Q2 2025, suppliers and buyers faced an environment marked by API availability challenges, fluctuating freight rates, and strategic inventory planning. Despite these pressures, consistent demand from OTC pharmaceutical consumption maintained a steady procurement pace. Evolving market trends were closely tied to major contributors like Europe, North America, and Asia-Pacific, which remain central to global paracetamol demand and pricing momentum.
To access real-time prices Request Sample
Current price levels reflect paracetamol’s critical role in the global pharmaceutical and healthcare industries, where supply chain disruptions and steady demand continue to support a stable to rising price trajectory across major formulation markets.
USA
In Q2 2025, paracetamol prices in the USA reached USD 3821/MT. Seasonal over-the-counter demand elevated buying activity, while high ocean freight costs and extended shipping timelines from Asian suppliers increased sourcing volatility. Limited domestic API production and FDA scrutiny on pharmaceutical imports further stressed supply-side dynamics.
China
Paracetamol prices reached USD 3732/MT in Q2 2025. Elevated para-aminophenol prices, stricter environmental regulations, and planned plant maintenance affected overall supply. At the same time, strong domestic and export-driven formulation demand pressured inventories across key API-producing hubs.
Germany
Prices in Germany stood at USD 3767/MT in June 2025. A steady rise in demand from hospitals and pharmaceutical distributors met with delays in securing API shipments from India and China. Port congestion and container availability issues disrupted timelines, while regulatory certifications slowed procurement cycles.
India
Paracetamol prices in India hit USD 2958/MT in Q2 2025. Input cost fluctuations for intermediates, environmental audits affecting production zones, and INR volatility shaped market movement. Fast inventory turnover by generic drugmakers further impacted procurement rhythm and price direction.
France
French paracetamol prices rose to USD 3965/MT in June 2025. Contract manufacturing faced delays due to slower API imports from Asia, particularly China. Limited capacity at local plants and rising energy and packaging costs further fueled upward price pressure across formulation units.
The global paracetamol market size reached USD 778.18 Million in 2024 and is projected to grow to USD 1,136.68 Million by 2033, expanding at a CAGR of 4.09% during 2025-2033. This growth is fueled by the widespread use of paracetamol in treating fever and pain-related conditions across populations of all age groups. Its affordability, OTC accessibility, and strong safety profile continue to drive demand in public healthcare systems and retail pharmacy channels.
Rising chronic illness prevalence, expanding elderly populations, and pandemic-led shifts toward preventive and self-managed care are also supporting growth. In Asia-Pacific, increased domestic production capacity, along with government efforts to localize pharmaceutical ingredient sourcing, further underpin the market. The push for sustainable and cost-effective drug manufacturing across the U.S., Europe, and emerging markets continues to create long-term opportunities for paracetamol suppliers.
Paracetamol remains one of the most essential active pharmaceutical ingredients globally due to its pain-relieving and antipyretic properties. The market continues to be driven by strong OTC consumption, consistent hospital procurement, and growing formulation exports. It is also a preferred option in countries looking to ensure pharmaceutical access for fever and flu-related illnesses at scale.
Key drivers include increasing investments in API manufacturing infrastructure, particularly in Asia; growing prevalence of diseases such as migraines and arthritis; and rising public and private healthcare spending in emerging economies. Moreover, regulatory flexibility for paracetamol formulations and rapid over-the-counter distribution networks make it a resilient product in times of both regular and crisis healthcare demand. As nations bolster their local pharma industries, paracetamol remains a staple API for domestic security and international trade.
IMARC’s report incorporates forecasting models that project near-term price movements based on evolving trade policies, raw material supply, and technological trends. These tools enable businesses to mitigate risk, enhance sourcing strategies, and support long-term planning.